What are the primary indications for Posterior Lumbar Interbody Fusion (PLIF) for 2 vertebrae in an adult patient with a history of chronic back pain and degenerative spinal conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Indications for Posterior Lumbar Interbody Fusion (PLIF) for 2 Vertebrae

PLIF for 2 vertebrae is indicated when patients have degenerative lumbar disease with documented instability (spondylolisthesis of any grade) or severe stenosis requiring extensive decompression that would create iatrogenic instability, combined with failure of comprehensive conservative management for at least 3-6 months. 1, 2

Core Diagnostic Requirements

Before PLIF can be considered medically necessary, all of the following criteria must be met:

  • Documented structural pathology: Moderate-to-severe spinal stenosis with neural compression, degenerative spondylolisthesis, or documented instability on flexion-extension radiographs 1, 2, 3
  • Symptomatic correlation: Clinical symptoms (radiculopathy, neurogenic claudication, or mechanical low back pain) must directly correlate with imaging findings at the proposed fusion levels 2, 4
  • Failed conservative management: Comprehensive treatment including formal physical therapy for minimum 6 weeks, trial of neuroleptic medications (gabapentin/pregabalin), anti-inflammatory therapy, and consideration of epidural steroid injections 2, 3

Specific Clinical Indications for 2-Level PLIF

Primary Indications (Grade B Evidence)

  • Degenerative spondylolisthesis with stenosis: Patients with symptomatic stenosis and any degree of spondylolisthesis achieve 93-96% excellent/good outcomes with decompression plus fusion versus only 44% with decompression alone 1, 2
  • Multilevel stenosis with instability: When contiguous levels demonstrate both severe stenosis requiring bilateral decompression and documented instability 2
  • Recurrent disc herniation with instability: Patients with recurrent herniation combined with chronic axial back pain, deformity, or documented instability 2
  • Post-laminectomy syndrome with iatrogenic instability: Revision cases where previous decompression created structural instability requiring stabilization 2

Secondary Indications (Grade C Evidence)

  • Severe degenerative disc disease at 2 levels: Patients with chronic discogenic low back pain refractory to intensive rehabilitation, particularly manual laborers or athletes with combined axial and radicular symptoms 2, 4
  • Degenerative scoliosis: When deformity correction and stabilization are required at 2 contiguous levels 5, 6

Critical Exclusion Criteria

PLIF should NOT be performed in the following scenarios:

  • Isolated stenosis without instability: Decompression alone is appropriate and fusion adds no benefit while increasing complication rates from 6-12% to 31-40% 2, 3
  • Primary disc herniation without instability: Level III evidence shows no significant difference between discectomy alone versus discectomy with fusion 2
  • Inadequate conservative management: Epidural injections alone provide only short-term relief (<2 weeks) and do not satisfy conservative treatment requirements 2, 3

Expected Outcomes and Fusion Rates

  • Clinical success: PLIF demonstrates 92-95% fusion rates with significant improvements in pain and functional outcomes when performed for appropriate indications 1, 7
  • Comparative effectiveness: Studies show no significant difference in clinical results or fusion rates between PLIF alone (95%), posterolateral fusion alone (92%), and combined PLIF+PLF (96%) at 3-year follow-up 1
  • Sagittal balance: PLIF provides better sagittal balance restoration compared to instrumented posterolateral fusion alone 1

Technical Considerations

Advantages of PLIF Technique

  • Direct neural decompression: Allows bilateral decompression of neural elements through posterior approach 1, 5
  • Anterior column support: Places graft within load-bearing column of the spine for biomechanical stability 5, 6
  • Lordosis restoration: Enables correction of sagittal alignment and disc height 5

Disadvantages and Complications

  • Dural retraction required: Bilateral approach necessitates greater thecal sac manipulation compared to TLIF 5, 8
  • Higher complication rates: Overall complication rates of 33.6% including dural tears, nerve root injury, and implant-related issues 8
  • Paraspinal muscle disruption: Traditional open approach causes iatrogenic injury to posterior tension band 5

Alternative Interbody Techniques

When PLIF is contraindicated or technically challenging, consider:

  • TLIF (Transforaminal Lumbar Interbody Fusion): Unilateral approach with less dural retraction, comparable fusion rates of 92-95%, preferred in revision cases with epidural scarring 1, 7, 6
  • LLIF/XLIF (Lateral approaches): Better radiologic outcomes and fewer intraoperative complications than PLIF, though with risk of lumbar plexus injury 5, 9
  • ALIF (Anterior Lumbar Interbody Fusion): Avoids posterior structures entirely, superior outcomes at L5-S1 specifically 2, 5

Common Pitfalls to Avoid

  • Performing fusion without documented instability: This exposes patients to unnecessary complication risks without clinical benefit 2, 3
  • Inadequate preoperative conservative management: Proceeding to surgery based solely on failed injections without completing formal physical therapy leads to poor patient selection 3
  • Adding posterolateral fusion to PLIF: Studies demonstrate no additional benefit but increased donor site pain, blood loss, and operative time 1
  • Misinterpreting disc degeneration alone as fusion indication: Degenerative changes without instability or spondylolisthesis do not justify fusion 2, 3

Related Questions

Is L5-S1 anterior lumbar interbody fusion (ALIF), posterior spinal instrumentation fusion (PSIF), and possible transforaminal lumbar interbody fusion (TLIF) medically indicated for a patient with progressive bilateral radiating leg pain, severe low back pain, and multilevel spondylosis, who has failed conservative treatments and has a history of coronary artery disease, diabetes, gastroesophageal reflux disease (GERD), hypertension, hyperlipidemia, and tobacco use?
Is L3-4 DLIF (Direct Lateral Interbody Fusion), laminectomy, facetectomy, and posterior instrumented fusion medically indicated for a patient with other intervertebral disc disorders, lumbar region, and spinal stenosis, lumbar region, without neurogenic claudication?
Is a re-exploration with reinstumentation of a previous fusion, decompression, and posterior lumbar interbody fusion (PLIF) medically indicated for a patient with spinal stenosis, spondylolisthesis, and radiculopathy, who has failed conservative therapy and has a history of previous lumbar fusion?
Is a combined Transforaminal Lumbar Interbody Fusion (TLIF)/Posterior Lumbar Spinal Fusion (PLSF) of L5-S1 with removal of pre-existing L3-L5 hardware medically indicated for a patient with lumbosacral spondylosis with radiculopathy and a history of lumbar spine fusion?
Is the requested procedure with CPT (Current Procedural Terminology) codes 22633, 22840, 63052, 63047, 22853, 20936, and 20930, along with inpatient level of care, medically necessary for a patient with low back pain radiating to the lower extremity and right foot who will undergo L5-S1 posterior lumbar decompression and fusion with TLIF (Transforaminal Lumbar Interbody Fusion) and right L4-5 hemilaminotomy with microdiscectomy?
What is the appropriate management for a patient with severe hypokalemia (potassium level of 2.2 mEq/L)?
What is the difference between bronchoscopy procedures coded as P180 and H190, especially in patients with chronic conditions like COPD, asthma, or heart disease?
Is it safe for an 18-year-old patient with a history of four seizures and a deep left cerebral cortex lesion to use Nas (nasal decongestant) or Vicks (camphor, menthol, and eucalyptus oil) for nasal congestion?
What are the considerations for a patient with a history of hepatitis B on entecavir (entacavir) when starting tofacitinib (tofacitinib) therapy?
When is the maximum effect of lispro (insulin lispro) seen in a patient with diabetes?
What is the appropriate workup for a patient presenting with bradycardia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.